News about Market

BioCryst Strengthens Rare-Disease Portfolio with USD 700 Million Acquisition of Astria

Under the terms of the agreement, Astria shareholders will receive USD 8.55 per share in cash along with 0.59 BioCryst shares for each Astria share, representing a premium of about fifty-four percent over Astria’s previous closing price.

Market | 15/10/2025 | By Darshana |  250

MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients

The launch of JAK inhibitors enhances the accessibility and affordability of advanced treatments for patients suffering from various autoimmune diseases, including Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, Crohn's Disease and Atopic Dermatitis. Both molecules are also approved by the US FDA.

Market | 14/10/2025 | By Dineshwori |  1056

Cadila Pharmaceuticals Introduces Dlorfast-M Tablets to Treat Allergic Rhinitis and Urticaria

Allergic rhinitis and urticaria are chronic health conditions that affect millions of people globally. Cadila Pharmaceuticals has introduced Dlorfast-M as a dual-action therapy targeting two pathways of the allergic response—histamine and leukotriene—aiming to provide wider and more effective symptom management.

Market | 14/10/2025 | By Dineshwori |  400

Bristol Myers Squibb Acquires Orbital Therapeutics

The acquisition of Orbital Therapeutics by Bristol Myers Squibb includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogramme cells in vivo with potential best-in-class profile for autoimmune diseases.

Market | 13/10/2025 | By Dineshwori |  389

Smartee Denti-Technology Launches Innovative Sleep Aligners to Treat Sleep Apnoea and Snoring

Chinese dental technology company Smartee Denti-Technology has announced the global launch of its Smartee Sleep Aligners, a new clear aligner series designed to manage obstructive sleep apnoea hypopnoea syndrome (OSAHS) and primary snoring (PS).

Market | 13/10/2025 | By Dineshwori |  213

AstraZeneca Plans to Increase Investment and Scope of its Virginia Manufacturing Facility to USD 4.5 Billion

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies.<br />

Market | 10/10/2025 | By Dineshwori |  232

Kernal Biologics receives USD 48 Million from ARPA-H

The funding received by Kernal Biologics from ARPA-H is to develop lower cost in vivo CAR T-cell therapies for hematological cancers.

Market | 09/10/2025 | By Dineshwori |  291

Revolutionising Mammography: BPL MedTech Brings LILAC for Faster, Safer Breast Cancer Screening

BPL Medical Technologies is committed to making breast cancer screening a regular part of women’s healthcare by offering LILAC, an advanced digital mammography unit.

Market | 09/10/2025 | By Dineshwori |  255

Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share

Rubicon Research Limited has announced the launch of its initial public offering (IPO) of equity shares with a face value of ?1 each, opening on 9 October 2025. The Anchor Investor bidding date is set for 8 October 2025, while the offer will close on 13 October 2025.
<br />

Market | 07/10/2025 | By Darshana |  388

Roche Pharma to Invest 1.5 Billion Swiss Francs in India Over Five Years, Boosting R&D and Access

The funding will be channelled into three critical areas, including research and development, expansion of core businesses, and work with initiatives like Ayushman Bharat to broaden access to innovative products for patients.

Market | 03/10/2025 | By Darshana |  534